Emerging Treatment Options for Sarcopenia in Chronic Liver Disease

Emerging Treatment Options for Sarcopenia in Chronic Liver Disease

Sarcopenia is characterized by a skeletal muscle disorder with progressive and generalized loss of muscle mass and function, and it increases the risk of adverse outcomes with considerable prevalence in patients with chronic liver disease. Sarcopenia in chronic liver disease underlies complicated an...

Full description

Bibliographic Details
Main Author:	Yun Kim
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Life
Subjects:	sarcopenia chronic liver disease muscle protein turnover cirrhosis non-alcoholic fatty liver disease
Online Access:	https://www.mdpi.com/2075-1729/11/3/250

Similar Items

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
by: Hwi Seung Kim, et al.
Published: (2023-01-01)

SARCOPENIA AND SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: Josilda Ferreira CRUZ, et al.

Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
by: Alessandra Musio, et al.
Published: (2023-04-01)

Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
by: Speranta Iacob, et al.
Published: (2022-06-01)

Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea
by: Hun Ju Lee, et al.
Published: (2021-11-01)

Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study
by: Yu-Ming Wang, et al.
Published: (2021-01-01)

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
by: Chisato Saeki, et al.
Published: (2021-07-01)

Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease
by: Goh Eun Chung, et al.
Published: (2019-06-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
by: Pegah Golabi, et al.
Published: (2020-12-01)

Clinically Meaningful Fatigue and Depression Are Associated with Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease
by: Anna F. Sheptulina, et al.
Published: (2023-05-01)

Definition of Sarcopenia in Chronic Liver Disease
by: Seong Wan Son, et al.
Published: (2021-04-01)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
by: Hong-Kyu Kim, et al.
Published: (2023-10-01)

Sarcopenia as a prognostic indicator of liver cirrhosis
by: Sung‐Eun Kim, et al.
Published: (2022-02-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
by: Hiroki Nishikawa, et al.
Published: (2020-07-01)

Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
by: Joon Ho Moon, et al.
Published: (2021-08-01)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
by: Pegah Golabi, et al.
Published: (2022-01-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
by: Guohong-Liu, et al.
Published: (2019-11-01)

Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
by: Silvia Espina, et al.
Published: (2023-08-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND SARCOPENIA
by: Pivtorak K. V., et al.
Published: (2022-11-01)

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
by: Karn Wijarnpreecha, et al.
Published: (2021-04-01)

Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?
by: Xuan-vinh Kevin Nguyen, et al.
Published: (2022-09-01)

Wasting Away with Cirrhosis: A Review of Hepatic Sarcopenia
by: Jan Freeman, et al.
Published: (2019-09-01)

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
by: Michihiro Iwaki, et al.
Published: (2023-02-01)

Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis
by: Andrea Gonzalez, et al.
Published: (2021-02-01)

An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia
by: Young Joo Yang, et al.
Published: (2021-03-01)

Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital
by: Jaejun Lee, et al.
Published: (2023-09-01)

Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
by: Thanaput Kunlayawutipong, et al.
Published: (2024-03-01)

Muscle depletion in cirrhotic patients assessed using computed tomography: a cross-sectional study
by: Elisa Sfoggia Romagna, et al.

Relationship between sarcopenia and fatty liver in middle-aged and elderly patients with type 2 diabetes mellitus
by: Li Quan, et al.
Published: (2024-04-01)

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease
by: Eduardo Castillo-Leon, et al.
Published: (2022-03-01)

Liver diseases: Perspective from the Philippines
by: Eric David Ornos, et al.
Published: (2023-05-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
by: Wah-Kheong Chan, et al.
Published: (2023-09-01)

Sarcopenia in children with chronic liver disease: Prevalence and impact on liver transplant outcomes
by: Silvio Veraldi, et al.
Published: (2022-10-01)

Knowing what’s out there: awareness of Non Alcoholic Fatty Liver Disease.
by: Vishal eGhevariya, et al.
Published: (2014-03-01)

Non-invasive diagnosis of liver steatosis: ready for primetime?
by: Nicolas Goossens
Published: (2019-07-01)

Risk factors for chronic liver disease in population of Central India: a case-control study from rural India
by: Shashank Banait, et al.
Published: (2021-01-01)